James T. Lin

发表

A Comparison Study of Replenishment Strategies in Vendor-Managed Inventory

Fu-Kwun Wang, James T. Lin, James T. Lin, 2014 .

Ingredients for success: a familial cancer clinic in an oncology practice setting.

James T. Lin, P. Duncan, 2011, Journal of oncology practice.

Epiphora Induced by Intermittent Docetaxel (Taxotere) in Patients with Non-small Cell Lung Cancer

James T. Lin, D. W. Spell, F. Estephan, 2003, Cancer investigation.

Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer

James T. Lin, K. Badani, J. McKiernan, 2016, PloS one.

Fluoropyrimidines by Leucovorin Role of Folylpolyglutamates in Biochemical Modulation of Updated

James T. Lin, D. Niedzwiecki, D. Priest, 2006 .

Prediction of antifolate efficacy in a rat sarcoma model

James T. Lin, J. Bertino, Wei Li, 1991, International journal of cancer.

Neoadjuvant chemotherapy in the treatment of muscle invasive bladder cancer with mixed histology.

James T. Lin, J. McKiernan, G. Hruby, 2013, The Canadian journal of urology.

Tissue Sarcomas Mechanisms of Natural Resistance to Antifolates in Human Soft Updated

James T. Lin, J. Bertino, M. Brennan, 2006 .

Development of Sensitive Assays to Detect Antifolate Resistance in Leukemia Blasts

James T. Lin, J. Bertino, T. Trippett, 1992 .

The basis for intrinsic drug resistance or sensitivity to methotrexate.

James T. Lin, J. Bertino, W. Li, 1989, Advances in enzyme regulation.

Unusual abdominal tumors: case 2. Intra-abdominal desmoplastic small round cell tumor.

James T. Lin, S. Xiao, V. Raja, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease.

James T. Lin, B. Schweitzer, J. Bertino, 1993, Leukemia.

Mechanisms of natural resistance to antifolates in human soft tissue sarcomas.

James T. Lin, J. Bertino, M. Brennan, 1992, Cancer research.

Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug.

James T. Lin, E. Mini, T. Mazzei, 1988, Cancer research.

Trimetrexate: a second generation folate antagonist in clinical trial.

James T. Lin, J. Bertino, J. Lin, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.